Thomas Steyer’s Kezar Life Sciences KZR Stock Holding History

Thomas Steyer’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,667	Closed	-$1.33M	–	109
2018 Q2	$1.33M	Buy	+7,667	New	+$1.34M	0.01%	94

Other funds holding KZR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Thomas Steyer's KZR Position: Q3 2018 in Review

Thomas Steyer sold out of Kezar Life Sciences (KZR) in Q3 2018, closing a stake of 7,667 shares — an estimated $1.33M sold.

Thomas Steyer first reported a position in KZR in Q2 2018 and held it in 1 quarter. The position peaked at $1.33M in Q2 2018. 37 funds tracked by Wall St. Rank hold KZR as of Q3 2018.

Thomas Steyer reported no remaining Kezar Life Sciences position as of Q3 2018 after selling out during the quarter.
Thomas Steyer sold 7,667 Kezar Life Sciences shares in Q3 2018, an estimated $1.33M.
Thomas Steyer first reported a position in Kezar Life Sciences in Q2 2018 and held it in 1 quarter.
Thomas Steyer's Kezar Life Sciences position peaked at $1.33M in Q2 2018.
37 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2018.

Based on Farallon Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.